A Text Messaging Intervention to Reduce Perinatal Depression Risk
PTMI
2 other identifiers
interventional
40
1 country
1
Brief Summary
Development and preliminary testing of a text messaging intervention that will reduce the risk of a major depressive episode and worsening depressive symptoms in perinatal individuals. The system will screen pregnant individuals, send tailored text messages with links to enhanced content, and will include a peer chat function.This accessible text platform will leverage both the ease of use inherent in text messages and the power of enhanced content drawn evidence from based behavioral interventions (Interpersonal Therapy).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2023
CompletedFirst Posted
Study publicly available on registry
November 7, 2023
CompletedStudy Start
First participant enrolled
September 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 27, 2026
January 1, 2026
1.2 years
May 1, 2023
January 25, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Edinburgh Prenatal Depression Scale
10-item continuous measure of depression. Self-report that will be administered by computer. Will be administered three times (for pre-pilot administered at screening, 2 weeks, and 4 weeks; for pilot administered at screening, 4 weeks, and 8 weeks). Items are scored 0-3, with a maximum score of 30. Higher scores show increased severity.
Week 4 for pre-pilot and week 8 for pilot, adjusted for baseline
General Self Efficacy Scale
10 item measure of self efficacy. Items are scored 1-4, with scores ranging between 10 and 40. A higher score indicates more self-efficacy. Will be administered three times (for pre-pilot administered at baseline, 2 weeks, and 4 weeks; for pilot administered at baseline, 4 weeks, and 8 weeks).
Week 4 for pre-pilot and week 8 for pilot, adjusted for baseline
System Usability Scale
10 items rated on a 1-5 scale, with scores ranging from 0-100, with a higher score indicating greater acceptability. Will be administered one times (for pre-pilot administered at 4 weeks; for pilot administered at 8 weeks).
Week 4 for pre-pilot and week 8 for pilot, adjusted for baseline
Patient engagement with text messages
Percentage of participants opening \>80% of text messages and clicking on \>30% of links to enhanced content.
0-8 weeks
Patient engagement with chat
Percentage of participants engaging with chat and endorsing 4 out of 5 on its utility.
0-8 weeks
Secondary Outcomes (3)
Diagnosis of a major depressive episode
Week 4 for pre-pilot and week 8 for pilot, adjusted for baseline
User Engagement Scale
Week 4 for pre-pilot and week 8 for pilot, adjusted for baseline
Perlin Mastery Scale
Week 4 for pre-pilot and week 8 for pilot, adjusted for baseline
Study Arms (2)
Text4Moms
EXPERIMENTALTexts will include video links that reinforce information relevant to Interpersonal Psychotherapy (IPT).
Educational Control
NO INTERVENTIONThe control condition will be limited to texts related to pregnancy, nutrition and sleep. We will avoid elements that have behavioral therapeutic effects. Although this condition is meant to constitute time and attention control, we will include material on recognizing depression and links to ways to attain depression treatment and suicide hotline information.
Interventions
A text messaging intervention that includes enhanced content such as tailoring, video links and a chat function
Eligibility Criteria
You may qualify if:
- English speaking
- "At risk" as determined by an Edinburgh Postnatal Depression Scale score of at least 9, or an average score \>3 on the 6-item Medical Outcomes Social Support Survey or history of depression in pregnancy or postpartum depression
- At least age 16
- Are willing and able to provide informed consent
- Are willing to use a smart phone to receive texts
You may not qualify if:
- In a major depressive episode
- Planning on terminating pregnancy
- Have panic disorder or substance use disorder
- Currently in behavioral health care treatment
- Blind individuals
- Permanently living in an institutional setting
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Worcester Polytechnic Institutecollaborator
- National Institute of Mental Health (NIMH)collaborator
- University of Massachusetts, Worcesterlead
- Yale Universitycollaborator
- Michigan State Universitycollaborator
Study Sites (1)
UMass Chan Medical School
Worcester, Massachusetts, 01655, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Kimberly Yonkers, MD
UMass Chan Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 1, 2023
First Posted
November 7, 2023
Study Start
September 5, 2024
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
January 27, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- 12 months after data analysis
- Access Criteria
- interest in postpartum depression
We welcome any interest in using or modifying the intervention materials developed under this project, which will be aided by our use of the Computerized Intervention Authoring System (CIAS) platform. Our overall plan will include presentations at national scientific meetings as well as publication of results, via reputable peer-reviewed journals and the National Library of Medicine/PubMed Central. We will deposit this dataset with the National Database for Clinical Trials Related to Mental Illness. We will indicate in publications and presentations where and how to access these data. Study materials and information regarding access to intervention content will be made available via the Open Science Framework (OSF). Individuals who would like our data can also complete a "data analysis requisition form" that describes their specific hypotheses with mock-ups of tables. All data will be de-identified before sharing. We will make the data available under a data sharing agreement.